Spots Global Cancer Trial Database for Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer

Official Title: Interest of Preoperative Immunonutrition in Liver Resection for Cancer

Study ID: NCT02041871

Conditions

Hepatectomy

Elective Hepatectomy

Malignant Tumors

Interventions

Oral immunonutrition

Placebo

Study Description

Brief Summary: To study the efficacy of preoperative immunonutrition in reducing postoperative morbidity after liver resection for cancer.

Detailed Description: Perioperative immunonutrition has been developed to improve the immuno metabolic host response and outcome in postoperative period and has been proven to be beneficial in reducing significantly postoperative infectious complications and length of hospital stay in patients undergoing elective gastrointestinal surgery for tumors. To date, the effects of preoperative oral immunonutrition (ORAL IMPACT) in non cirrhotic patients undergoing liver resection for cancer are unknown. The purpose of this study is to determine whether the administration of a short-term preoperative oral immunonutrition can reduce postoperative morbidity in non-cirrhotic patients undergoing liver resection for malignant tumours.